Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Tissue Antigens|January 30, 2007
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypesK Wiencke, T H Karlsen, K M Boberg, et al.Hepatology (Baltimore, Md.)|November 21, 2007
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphismsEspen Melum, Tom H Karlsen, Erik Schrumpf, et al.Gastroenterology|April 9, 2008
The natural history of small-duct primary sclerosing cholangitisEinar Björnsson, Rolf Olsson, Annika Bergquist, et al.Gastroenterology|September 6, 2006
Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitisTom H Karlsen, Benedicte A Lie, Kathrine Frey Frøslie, et al.Arzneimittel-Forschung|August 1, 1997
Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogsM Boberg, H J Ahr, B Beckermann, et al.Gut|October 16, 2002
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosisE Björnsson, K M Boberg, S Cullen, et al.Journal of Hepatology|March 29, 2000
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic developmentK M Boberg, E Schrumpf, A Bergquist, et al.Journal of Internal Medicine|May 1, 1990
Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre StudyL Janzon, D Bergqvist, J Boberg, et al.Arzneimittel-Forschung|October 1, 1989
Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and manH J Ahr, M Boberg, H P Krause, et al.European Journal of Clinical Investigation|February 15, 2019
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitisFrancesca Saffioti, Davide Roccarina, Mette Vesterhus, et al.Pageof 12